PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,210 | -85.5% | 15,289 | -80.5% | 0.01% | -86.0% |
| Q2 2023 | $276,929 | +9.8% | 78,450 | -3.9% | 0.05% | -5.7% |
| Q1 2023 | $252,203 | -36.8% | 81,619 | -13.5% | 0.05% | -37.6% |
| Q4 2022 | $399,122 | +504.7% | 94,355 | +236.3% | 0.08% | +431.2% |
| Q3 2022 | $66,000 | -35.9% | 28,056 | -22.3% | 0.02% | -61.9% |
| Q2 2022 | $103,000 | -41.5% | 36,130 | -41.0% | 0.04% | -45.5% |
| Q1 2022 | $176,000 | +91.3% | 61,218 | +102.0% | 0.08% | +48.1% |
| Q4 2021 | $92,000 | -36.1% | 30,308 | +93.0% | 0.05% | +6.1% |
| Q2 2021 | $144,000 | – | 15,705 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |